<p>TNF Pharmaceuticals (TNFA) 刚刚发布了更新。</p>
<p>2025 年 9 月 22 日，TNF Pharmaceuticals 正式更名为 Q/C Technologies，反映其向量子级计算的战略转型。该公司的股票于 2025 年 9 月 25 日在纳斯达克证券市场以新股票代码 ‘QCLS’ 开始交易。这一转变与 Q/C Technologies 专注于光子计算及其对 LightSolver 平台的独占权利相一致，旨在提升其市场地位和股东价值。</p>
<p><strong>关于 TNF Pharmaceuticals 的更多信息</strong></p>
<p>Q/C Technologies，前身为 TNF Pharmaceuticals，专注于量子级计算的高性能计算行业。该公司拥有 LightSolver 的光速激光处理单元的全球独占权，该单元用于量子级加密货币应用，使其处于这一创新计算范式的前沿。</p>
<p><strong>平均交易量：</strong> 1,611,301</p>
<p><strong>技术情绪信号：</strong> 强烈卖出</p>
<p><strong>当前市值：</strong> 929 万美元</p>

TNFA

<p>TNF Pharmaceuticals 已于 2025 年 9 月 22 日更名为 Q/C Technologies，反映其向量子级计算的战略转型。该公司的股票现在在纳斯达克以 “QCLS” 的股票代码交易。这一变化与其对光子计算的关注以及对 LightSolver 平台的独占权相一致，增强了其市场地位。Q/C Technologies 主要从事高性能计算，特别是在量子级加密货币应用方面，目前市值为 929 万美元，平均交易量为 1,611,301</p>

<p>TNF Pharmaceuticals ( (TNFA) ) just unveiled an update.</p>
<div class="lb-trans"><p>TNF Pharmaceuticals (TNFA) 刚刚发布了更新。</p>
</div><p>On September 22, 2025, TNF Pharmaceuticals officially changed its name to Q/C Technologies, reflecting its strategic shift towards quantum-class computing. The company’s stock began trading under the new ticker symbol ‘QCLS’ on the Nasdaq Stock Market on September 25, 2025. This transition aligns with Q/C Technologies’ focus on photonic computing and its exclusive rights to LightSolver’s platform, aiming to enhance its market position and shareholder value.</p>
<div class="lb-trans"><p>2025 年 9 月 22 日，TNF Pharmaceuticals 正式更名为 Q/C Technologies，反映其向量子级计算的战略转型。该公司的股票于 2025 年 9 月 25 日在纳斯达克证券市场以新股票代码 ‘QCLS’ 开始交易。这一转变与 Q/C Technologies 专注于光子计算及其对 LightSolver 平台的独占权利相一致，旨在提升其市场地位和股东价值。</p>
</div><p><strong>More about TNF Pharmaceuticals</strong></p>
<div class="lb-trans"><p><strong>关于 TNF Pharmaceuticals 的更多信息</strong></p>
</div><p>Q/C Technologies, formerly known as TNF Pharmaceuticals, operates in the high-performance computing industry with a focus on quantum-class computing. The company holds exclusive global rights to LightSolver’s light-speed laser processing unit, which is used for quantum-class cryptocurrency applications, positioning it at the forefront of this innovative computing paradigm.</p>
<div class="lb-trans"><p>Q/C Technologies，前身为 TNF Pharmaceuticals，专注于量子级计算的高性能计算行业。该公司拥有 LightSolver 的光速激光处理单元的全球独占权，该单元用于量子级加密货币应用，使其处于这一创新计算范式的前沿。</p>
</div><p><strong>Average Trading Volume:</strong> 1,611,301</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 1,611,301</p>
</div><p><strong>Technical Sentiment Signal:</strong> Strong Sell</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 强烈卖出</p>
</div><p><strong>Current Market Cap:</strong> $9.29M</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 929 万美元</p>
</div>

TNF Pharmaceuticals 更名为 Q/C Technologies